AIM
SCPH

Alambic Investment Management’s scPharmaceuticals SCPH Stock Holding History

Alambic Investment Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-38,623
Closed -$284K – 143
2020
Q2 		$284K Sell
38,623
-2,900
-7% -$25.5K 0.71% 53
2020
Q1 		$307K Sell
41,523
-9,500
-19% -$68.9K 0.74% 54
2019
Q4 		$289K Sell
51,023
-4,791
-9% -$24.5K 0.24% 167
2019
Q3 		$328K Sell
55,814
-4,033
-7% -$22.7K 0.25% 155
2019
Q2 		$191K Buy
+59,847
New +$196K 0.12% 240

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return